News from the healthcare data industry
BARCELONA, Spain, June 24, 2024 /PRNewswire/ — Aetion®, the global leader in real-world evidence (RWE) technology and analytics, announced today the creation of an RWE technology hub in Barcelona, Spain, to convene the...
Partnership now includes access to five comprehensive oncology datasets, enhancing real-world evidence in cancer research. We are delighted to partner with xCures, as their datasets provide a unique lens into...
OTTAWA, ON, Sept. 12, 2023 /PRNewswire/ — Today, Aridhia and Replica Analytics Ltd., an Aetion® company, announced a new partnership to bring to market a complete, secure, and privacy-protective data sharing solution...
NEW YORK, Aug. 25, 2023 /PRNewswire/ — Aetion®, the global leader in real-world evidence (RWE) technology and analytics, is pleased to announce that ‘A Screening Tool to Evaluate whether Using Real-world Data to Support an...
TORONTO, May 25, 2023 /PRNewswire/ – Private AI, a leading provider of data privacy software solutions, and Replica Analytics Ltd., an Aetion® company, the leading Synthetic Data Generation technology provider for the healthcare industry,...
Aetion® Discover helps define and understand populations, outcomes, treatments, and trends of interest. NEW YORK, May 8, 2023 /PRNewswire/ — Aetion®, the global leader in real-world evidence technology and analytics, today announced...
Aetion® Discover helps define and understand populations, outcomes, treatments, and trends of interest. NEW YORK, May 8, 2023 /PRNewswire/ — Aetion®, the global leader in real-world evidence technology and analytics, today announced...
NEW YORK, April 25, 2023 /PRNewswire/ — Aetion®, the global leader in real-world evidence (RWE) technology and analytics, is pleased to announce the culmination of the RCT-DUPLICATE demonstration project, with complete findings...
Latest version of trusted synthetic data generation software boasts intuitive new UI VENICE, Italy, April 20, 2023 /PRNewswire/ – Replica Analytics Ltd., an Aetion® company, today announced the release of Replica Synthesis 3.0,...
Collaboration will leverage global patient registries to deliver real-world evidence across rare neuromuscular diseases to biopharmaceutical companies NEW YORK and NEWCASTLE, England, Feb. 22, 2023 /PRNewswire/ — TREAT-NMD Services Ltd, the business arm of...